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It is evident that the gut microbiota and factors that influence its composition and activity 35 
influence human metabolic, immunological, and developmental processes. We previously 36 
reported that extreme physical activity with associated dietary adaptations, such as that 37 
pursued by professional athletes, is associated with changes in faecal microbial diversity and 38 
composition relative to that of individuals with a more sedentary lifestyle. Here we address 39 
the impact of these factors on the functionality/metabolic activity of the microbiota which 40 
reveals even greater separation between exercise and a more sedentary state.  41 
Design 42 
Metabolic phenotyping and functional metagenomic analysis of the gut microbiome of 43 
professional international rugby union players (n = 40) and controls (n = 46) was carried out 44 
and results were correlated with lifestyle parameters and clinical measurements (e.g. dietary 45 
habit and serum creatine kinase, respectively) 46 
Results 47 
Athletes had relative increases in pathways (e.g. amino acid and antibiotic biosynthesis and 48 
carbohydrate metabolism) and faecal metabolites (e.g. microbial produced short chain fatty 49 
acids [SCFAs] acetate, propionate, and butyrate) associated with enhanced muscle turnover 50 




Differences in faecal microbiota between athletes and sedentary controls show even greater 53 
separation at the metagenomic and metabolomics than at compositional levels and provide 54 
added insight into the diet-exercise-gut microbiota paradigm. 55 
SUMMARY 56 
What is already known about this subject? 57 
Taxonomic and functional compositions of the gut microbiome are emerging as biomarkers 58 
of human health and disease. 59 
Physical exercise and associated dietary adaptation are linked with changes in the 60 
composition of the gut microbiome. 61 
Metabolites such as short chain fatty acids (SCFAs) have an impact on a range of health 62 
parameters including immunity, colonic epithelial cell integrity, and brain function.  63 
What are the new findings? 64 
Our original observation of differences in gut microbiota composition in elite athletes is 65 
confirmed and the separation between athletes and those with a sedentary lifestyle is even 66 
more evident at the functional or metabolic level. Microbial derived SCFAs are enhanced 67 
within the athletes. 68 
How might it impact on clinical practice in the foreseeable future? 69 
The findings provide new evidence supporting the link between exercise and metabolic 70 
health. The findings provide a platform for the rational design of diets for those engaged in 71 
vigorous exercise. The identification of specific alterations in the metabolic profile of 72 
4 
 
subjects engaged in high levels of exercise provides insight necessary for future efforts 73 
towards targeted manipulation of the microbiome. 74 
INTRODUCTION 75 
Regular exercise challenges systemic homeostasis resulting in a breadth of multi-organ 76 
molecular and physiological responses, including many that centre on immunity, metabolism 77 
and the microbiome-gut-brain axis.[1-5]  Exercise exhibits systemic and end-organ anti-78 
inflammatory effects, as well as contributing to more efficient carbohydrate metabolism, in 79 
addition to trophic effects at the level of the central nervous system.[6, 7] In fact, increasing 80 
physical activity offers an effective treatment and preventative strategy for many chronic 81 
conditions in which the gut microbiome has been implicated.[8-10] Conversely, a sedentary 82 
lifestyle is a major contributing factor to morbidity in developed Western society and is 83 
associated with heightened risk of numerous diseases of affluence, such as obesity, diabetes, 84 
asthma, and cardiovascular disease.[11-14] Recent evidence supports an influential role for 85 
the gut microbiome in these diseases.[15-23]  86 
 The concept that regular exercise and sustained levels of increased physical activity 87 
foster or assist the maintenance of a preferential intestinal microbiome has recently gained 88 
momentum and interest.[24-29] Previously, using 16S rRNA amplicon sequencing, we 89 
demonstrated taxonomic differences in gut microbiota between an elite athlete cohort of 90 
international-level rugby players and a group of age-matched high (>28 kg/m2) and low (<25 91 
kg/m2) BMI controls.[26] This analysis illustrated a significantly greater intestinal microbial 92 
diversity amongst the athletes compared to both control groups. This taxonomic diversity 93 
significantly correlated with exercise and dietary protein consumption. However, the 94 
possibility existed that these differences did not equate to differences at a functional level. 95 
Here, we re-examine the microbiome in these participants by whole metagenome shotgun 96 
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sequencing to provide deeper insight into taxonomic composition and metabolic potential and 97 
by complementary metabolic phenotyping analyses of host- and microbial-derived (urine and 98 
faecal respectively) metabolic profiles. This analysis shows that the differences in the gut 99 
microbiota between athletes and controls  is even more pronounced at the functional 100 
metabolic level than at the compositional level as previously reported and provides further 101 
rationale for prospective controlled studies to unravel the relationship between diet, exercise 102 
and the gut microbiome. 103 
RESULTS 104 
The study groups were comprised of professional male athletes (n = 40) and healthy controls 105 
(n = 46).[26] To better represent the variability of BMI in the athletes, controls were 106 
classified as either low BMI (n = 22, BMI ≤ 25.2) or high BMI (n = 24, BMI ≥ 26.5). 107 
Participants made no report of gastrointestinal (GI) distress or alterations of GI transit time 108 
throughout the course of the initial study. 109 
Functional structure of the enteric microbiome correlates with athletic state 110 
Functional metagenomic analysis of faecal samples allowed for the prediction of the 111 
operational potential of each individual’s microbiota. In total, 19,300 taxonomically linked 112 
metabolic pathways were identified in at least one individual. Comparison of phylogenetic 113 
constructions derived from the 16S rRNA amplicon data of our previous study and the 114 
functional data of this present report reveals a greater level of identification at higher levels 115 
of taxonomy (e.g. phylum) for 16S sequences,[26] while the metagenomic data had greater 116 
fidelity  and superior resolution of lower levels of taxonomy (e.g. species) (Fig. 1). Consistent 117 
with previous results, the microbiota of the athletes were significantly more diverse than that 118 
of both the low and high BMI control groups at the functional level (Fig. 2A). Furthermore, 119 
our previous findings of an enrichment of Akkermansia in athletes was corroborated by the 120 
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presence of significantly higher proportions of metabolic pathways associated with this genus 121 
in athletes when compared to high BMI controls (p < 0.001). Correlation analysis revealed 122 
that, of the total 19,300 pathways, 98 were significantly altered between the three cohorts (p 123 
< 0.05) (Supplementary table 1). Subsequently, large-scale functional dissimilarity between 124 
athletes and controls was determined and distinct patterns of pathway composition between 125 
groups were revealed (Supplementary Fig. 1A). This functional distinction remained true 126 
whether applied to total pathway data or to the statistically significant subset of pathways 127 
(Supplementary Fig. 1B). Correlation of pathways present in at least one member from both 128 
cohorts further exemplified the uniformity of the athletes and the division between the 129 
athletes and control groups (Supplementary Fig. 1C). Separation according to group 130 
membership was further illustrated through Principal Coordinate Analysis (PCoA), with 131 
statistical support of the significant separation between the athletes and both control groups 132 
(p < 0.05) (Fig. 2B). This was also the case for the statistically significant subset of pathways 133 
(Supplementary Fig. 1D). Principal Component Analysis (PCA) supplemented with a 134 
Correspondence Analysis (CA) and k-Nearest Neighbor (k-NN) semi-supervised learning 135 
approach cast further light (i.e. visualization of robustly defined class associations of specific 136 
individuals within the groups) on the clustering of participants within and between cohorts 137 
(Supplementary Fig. 1E). 138 
Pathways exhibiting statistically significant variation between the athletes and both control 139 
groups were organised according to MetaCyc metabolic pathway hierarchy classification (34 140 
metabolic categories), highlighting a number of differences (Fig. 3A, Supplementary table 2). 141 
Distinct clustering patterns were observed within each cohort, with the high BMI control 142 
group having the lowest average abundance scores across 31 metabolic pathway categories 143 
(the exceptions being Vitamin Biosynthesis (VB), Lipid Biosynthesis (LB), and Amino Acid 144 
Biosynthesis (AAB) categories). The athlete group had the highest mean abundance across 29 145 
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of the 34 metabolic categories (e.g. Carbohydrate Biosynthesis [CB], Cofactor Biosynthesis 146 
[CfB], and Energy Metabolism [EM]) (Supplementary table 2).  147 
Numerous statistically significant (p < 0.05) associations were identified between pathway 148 
abundances and serum Creatine Kinase—an enzymatic marker of muscle activity (CK, IU/L), 149 
total bilirubin (IU/L) and dietary macronutrient intake of protein (g/day), fibre (g/day), 150 
carbohydrates (g/day), sugars (g/day), starch (g/day), fat (g/day), and total energy (KJ/day) 151 
(Fig. 3B). Each group was represented by distinct association profiles of the correlation 152 
between clinical measurements and metagenomic pathways. Dietary factors, sugars and other 153 
carbohydrates, as well as energy intake, provide the majority of the correlation for the control 154 
groups whereas the athlete group was predominantly correlated with CK, total bilirubin, and 155 
total energy intake. Of the total number of metabolic pathways with associations to the 156 
clinical data from all three groups (10,760; data not shown), relevant pathways related to the 157 
production of secondary metabolites, co-factors, and SCFAs were identified (e.g. biotin 158 
biosynthesis and pyruvate fermentation to butanoate). 159 
Distinct differences between host and microbial metabolites in athletes and controls 160 
A combination of multi-platform metabolic phenotyping and multivariate analysis based on 161 
Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA) was used to compare 162 
urinary and faecal samples from athletes and controls. The cross-validated (CV) OPLS-DA 163 
models show strong differences between athletes and controls in urine samples by proton 164 
nuclear magnetic resonance (1H-NMR) analysis (R2Y=0.86, Q2Y=0.60, Fig. 2C), hydrophilic 165 
interaction ultra-performance liquid chromatography mass spectroscopy (HILIC UPLC-MS) 166 
positive mode analysis (R2Y=0.85, Q2Y=0.74, Supplementary Fig. 2A) and reverse phase 167 
ultra-performance liquid chromatography mass spectroscopy (RP UPLC-MS) in both positive 168 
and negative mode analysis (R2Y=0.83, Q2Y=0.73, and R2Y=0.83, Q2Y=0.67, 169 
8 
 
Supplementary Fig. 2B and 2C respectively). Likewise, the CV-OPLS-DA models comparing 170 
faecal samples, although weaker than the urine models, reveal significant differences between 171 
athletes and controls by 1H-NMR analysis (R2Y=0.86, Q2Y=0.52, Fig. 2D) and HILIC 172 
UPLC-MS positive mode analysis (R2Y=0.65, Q2Y=0.34, Supplementary Fig 2D). 173 
The loadings of the pairwise OPLS-DA models were used to identify metabolites 174 
discriminating between the two classes. Athletes’ 1H-NMR metabolic phenotypes were 175 
characterised by higher levels of trimethylamine-N-oxide (TMAO), L-carnitine, 176 
dimethylglycine, O-acetyl carnitine, proline betaine, creatinine, acetoacetate, 3-hydroxy-177 
isovaleric acid, acetone, N-methylnicotinate, N-methylnicotinamide, phenylacetylglutamine 178 
(PAG) and 3-methylhistidine in urine samples and higher levels of propionate, acetate, 179 
butyrate, trimethylamine (TMA), lysine, and methylamine in faecal samples, relative to 180 
controls. Beta-alanine betaine was higher in both faecal and urine samples of athletes. 181 
Athletes were further characterised by lower levels of glycerate, allantoin and succinate and 182 
lower levels of glycine and tyrosine relative to controls in urine and faecal samples, 183 
respectively (Supplementary Table 3). 184 
While numerous metabolites discriminated significantly between athletes and controls with 185 
RP UPLC-MS positive (490) and negative (434) modes for urine, as well as with HILIC 186 
UPLC-MS positive mode for urine (196) and faecal water (3), key metabolites were 187 
structurally identified using the strategy described below. UPLC-MS analyses revealed 188 
higher urinary excretion of N-formylanthranilic acid, hydantoin-5-propionic acid, 3-Carboxy-189 
4-methyl-5-propyl-2-furanpropionic acid (CMPF), CMPF glucuronide, trimetaphosphoric 190 
acid, acetylcarnitine - C2, propionylcarnitine - C3, isobutyrylcarnitine – C4, 2-191 
Methylbutyroylcarnitine - C5, Hexanoylcarnitine - C6, C9:1-carnitine, L-valine, nicotinuric 192 
acid, 4-pyridoxic acid and creatinine in athletes relative to controls. Levels of glutamine, 7-193 
methylxanthine, imidazoleacetic acid, isoquinoline / quinolone were lower in athletes’ 194 
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urinary samples relative to controls. Additionally, 16 unknown glucuronides were lower in 195 
the athlete samples (Supplementary Table 4). 196 
SCFA levels in faeces measured by targeted GC-MS showed significantly higher levels of 197 
acetate (p < 0.001), propionate (p < 0.001), butyrate (p < 0.001) and valerate (p = 0.011) in 198 
athletes relative to controls. Isobutyrate and isovalerate did not differ significantly between 199 
the groups (Fig. 4B, Supplementary Table 5). Furthermore, concentrations of propionate 200 
strongly correlated to protein intake while butyrate was shown to have a strong association 201 
with intake of dietary fibre (Supplementary Table 6). 202 
 203 
Correlating metabonomic and metagenomic results 204 
Correlation analysis between targeted measurements of SCFAs and taxonomic data from 16S 205 
rRNA sequencing revealed a number of correlations that remained significant following 206 
correction; Roseburia was positively correlated with acetate (p = 0.004) and butyrate (p = 207 
0.018) while Family XIII Incertae Sedis was positively correlated with isobutyrate (p < 208 
0.001), isovaleric acid (p < 0.001) and valeric acid (p = 0.008) (Fig. 4A, Supplementary 209 
Table 7). 210 
 211 
SCFAs were also correlated with pathway relative abundances, with all SCFAs associating 212 
with considerably more pathways in the athletes versus the controls (Fig. 4C). Multiple 213 
statistically significant (7,948) (p < 0.05) correlations between the metabolic pathways and 214 
SCFAs were identified (Supplementary Table 8). Two distinct blocks of proportionately 215 
discriminant correlations were observed with isobutyric and isovaleric acids, which were 216 
more abundant in the athletes while acetic and butyric acids were more proportionately 217 
abundant in controls. Correlations of the SCFA concentrations to pathways related to 218 
fermentation, biosynthesis, or modification of fatty acids were identified among the 219 
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numerous other associations (see supplementary table 8 for complete list). Additional 220 
correlations of metabolic pathways against well-identified metabolites detected from both 221 
faecal water (Fig. 5A and 5C) and urine (Fig. 5B and 5D) presented numerous significant 222 
associations (6,186 and 13,412, respectively; data not shown) (p < 0.05). It was also observed 223 
that 16 genera correlated with 12 metabolites (Supplementary Table 9). 224 
DISCUSSION 225 
The results confirm enhancement of microbial diversity in athletes compared with controls. 226 
Supporting previous insights into the beneficial influence of physical exercise and associated 227 
diet on the compositional structure of the gut microbiota,[25, 26, 30] this study has extended 228 
the paradigm to include links between physical fitness and the functional potential of the gut 229 
microbiota and its metabolites. It must be conceded that some athletes, although fit may not 230 
necessarily be more healthy.[31]   231 
Athletes have an increased abundance of pathways that—giving an equivalent amount of 232 
expression activity—could be exploited by the host for potential health benefit, including 233 
biosynthesis of organic cofactors and antibiotics, as well as carbohydrate degradation and 234 
secondary metabolite metabolism compared to both control groups.[32] Furthermore, athletes 235 
have an enriched profile of SCFAs, previously associated with numerous health benefits and 236 
a lean phenotype.[33-35] While interpretation of SCFA data can be difficult as levels 237 
represent a combination of SCFA production and host-absorption rates, it is notable that , as 238 
previously presented, the athletes’ diet maintained significantly higher quantities of fibre 239 
intake [29]. This along with an increased number of detected SCFA pathways in the athletes 240 
would be conducive to an enhanced rate of SCFA production[36] 241 
It was noted that athletes excreted proportionately higher levels of the metabolite TMAO, an 242 
end product metabolite of dietary protein degradation. Elevated TMAO has been observed in 243 
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patients with cardiovascular disease and atherosclerosis, highlighting a potential downside to 244 
increased protein intake.[15-17, 22, 37] However, TMAO is also found in high levels in the 245 
urine of Japanese populations,[38] who do not have high risk for CVD. Similarly to these 246 
populations, the athletes’ diet contained a significantly greater proportion of fish. Our current 247 
understanding of the implications of this result remains limited and requires elaboration in 248 
future studies. Furthermore, pathway abundance in a metagenome merely reflects functional 249 
potential and not necessarily increased expression in situ.  250 
Variance of metagenomic composition between athletes and controls was exemplified with 251 
unique pathway-pathway correlations between the two groups. Analysis of categorically 252 
arranged pathway abundances within the separate cohorts provided additional insight into the 253 
previously described dichotomy between the microbiota of athletes and high BMI controls. 254 
The two groups displayed distinct structures of functional capacity, separately oriented to 255 
operate under the different physiological milieu of the two groups. Notably, from a functional 256 
perspective, the microbiota of the low BMI group was more similar to the athletes. The low 257 
BMI controls were generally engaged in a modestly active-lifestyle, reflected by their 258 
leanness and increased levels of CK. It is speculative but not implausible, that moderate 259 
improvements in physical activity, for overweight and obese individuals may confer the 260 
beneficial metabolic functions observed within the athlete microbiome.  261 
Dietary contributions to the functional composition of the enteric microbial system are also 262 
evident in our study. The relative abundances of pathways related to fundamental metabolic 263 
function—amino acid biosynthesis, vitamin biosynthesis, and lipid biosynthesis—were 264 
higher on average within the high BMI control group when compared to the athlete group. 265 
The mechanisms behind these differences are unclear and might reflect chronic adaptation of 266 
the athlete gut microbiome; possibly due to a reduced reliance on the corresponding 267 
biosynthetic capacities of their gut microbiota. On the contrary, the athlete microbiome 268 
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presents a functional capacity that is primed for tissue repair and to harness energy from the 269 
diet with increased capacity for carbohydrate, cell structure and nucleotide biosynthesis, 270 
reflecting the significant energy demands and high cell-turnover evident in elite sport.  271 
Remarkably, our examination of pathway correlation to dietary macronutrients and 272 
plasma CK, as a biomarker of exercise,[39] is suggestive of an impact of physical activity 273 
upon the utilization of dietary nutrients by the microbiota of the gut. Comparing athletes to 274 
both high and low BMI controls, a greater number of pathways correlating to specific 275 
macronutrients with the controls suggests a shift in the dynamics of these varied metabolic 276 
functions. The impact of the athletes’ increased protein intake compared to both control 277 
groups was evident in the metabolomic phenotyping results. By-products of dietary protein 278 
metabolism (mostly by microbes) including TMAO, carnitines, trimethylamine, 3-Carboxy-279 
4-methyl-5-propyl-2-furanpropionic acid, and 3-hydroxy-isovaleric acid are all elevated in 280 
the athlete cohort. Of particular interest is 3-hydroxy-isovaleric acid (potentially from egg 281 
consumption) which has been demonstrated to have efficacy for inhibiting muscle wasting 282 
when used in conjunction of physical exercise.[40] The compound is also commonly used as 283 
a supplement by athletes to increase exercise-induced gains in muscle size, muscle strength, 284 
and lean body mass, reduce exercise-induced muscle damage, and speed recovery from high-285 
intensity exercise.[41] Numerous metabolites associated with muscle turnover—creatine, 3-286 
methylhistidine, and L-valine—and host metabolism—carnitine—are elevated in the athlete 287 
groups. Metabolites derived from vitamins and recovery supplements common in 288 
professional sports, including glutamine, lysine, 4-pyridoxic acid, and nicotinamide, are also 289 
raised in the athlete group. It is notable that PAG—a microbial conversion product of 290 
phenylalanine—has been associated with a lean phenotype, and is increased in the 291 
athletes.[42] Furthermore, PAG positively correlates with the genus Erysipelotrichaceae 292 
Incertae Sedis, which we have previously noted to be present in relatively higher proportions 293 
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in the athlete group compared to both control groups. PAG is the strongest biomarker post 294 
bariatric surgery, where it is associated with an increase in the relative proportions of 295 
Proteobacteria as observed here in the athlete group. Within the SCFAs, two distinct clusters 296 
were observed; acetic acid, propionic acid and butyric acid correlate with dietary contributors 297 
(fibre and protein), while isobutyric acid, isovaleric acid and valeric acid correlate with 298 
microbial diversity. The same clusters are observed when correlating with individual taxa, in 299 
support of previously observed links between SCFAs and numerous metabolic benefits and a 300 
lean phenotype.[33-35] 301 
Our on-going work in this area with non-athletes engaging in a structured exercise regime 302 
looks to further explore components of the exercise and diet-microbiome paradigm, which 303 
along with the present study may inform the design of exercise and fitness programs, 304 
including diet design in the context of optimizing microbiota functionality for both athletes 305 
and the general population.  306 
   307 
MATERIALS AND METHODS 308 
Study population 309 
Elite professional male athletes (n = 40) and healthy controls (n = 46) matched for age and 310 
gender were enrolled in 2011 as previously described in the study.[26] Due to the range of 311 
physiques within a rugby team (player position dictates need for a variety of physical 312 
constitutions, i.e. forward players tend to have larger BMI values than backs, often in the 313 
overweight/obese range) the recruited control cohort was subdivided into two groups. In 314 
order to more completely include control participants, the BMI parameter for group inclusion 315 
was adjusted to BMI ≤ 25.2 and BMI ≥ 26.5 for the low BMI and high BMI groups 316 
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respectively. Approval for this study was granted by the Cork Clinical Research Ethics 317 
Committee. 318 
Acquisition of clinical, exercise and dietary data 319 
Self-reported dietary intake information was accommodated by a research nutritionist within 320 
the parameters of a food frequency questionnaire (FFQ) in conjunction with a photographic 321 
food atlas as per the initial investigation.[26] Fasting blood samples were collected and 322 
analysed at the Mercy University Hospital clinical laboratories, Cork. As the athletes were 323 
involved in a rigorous training camp we needed to assess the physical activity levels of both 324 
control groups. To determine this we used an adapted version of the EPIC-Norfolk 325 
questionnaire.[43] Creatine kinase levels were used as a proxy for level of physical activity 326 
across all groups. 327 
Preparation of Metagenomic libraries 328 
DNA derived from faecal samples was extracted and purified using the QIAmp DNA Stool 329 
Mini Kit (cat. no. 51504) prior to storage at -80°C. DNA libraries were prepared with the 330 
Nextera XT DNA Library Kit (cat. no. FC-131-1096) prior to processing on the Illumina 331 
HiSeq 2500 sequencing platform (see supplementary methods for further detail). 332 
Metagenomic statistical and bioinformatic analysis 333 
Delivered raw FASTQ sequence files were quality checked as follows: contaminating 334 
sequences of human origin were first removed through the NCBI Best Match Tagger 335 
(BMTagger). Poor quality and duplicate read removal, as well as trimming was implemented 336 
using a combination of SAM and Picard tools. Processing of raw sequence data produced a 337 
total of 2,803,449,392 filtered reads with a mean read count of 32,598,248.74 (± 10,639,447 338 
SD) per each of the 86 samples. These refined reads were then subjected to functional 339 
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profiling by the most recent iteration of the Human Microbiome Project (HMP) Unified 340 
Metabolic Analysis Network (HUMAnN2 v. 0.5.0) pipeline.[44] The functional profiling 341 
performed by HUMAnN2 composed tabulated files of microbial metabolic pathway 342 
abundance and coverage derived from the Metacyc database.[45] Microbial pathway data was 343 
statistically analysed in the R software environment (v. 3.2.2) (for further details see 344 
supplementary methods).[46] All presented p values were corrected for multiple comparisons 345 
using the Benjamini-Hochberg False Discovery Rate (pFDR) method.[47] 346 
 347 
Metabolic profiling 348 
Urine and faecal samples were prepared for metabonomic analysis as previously 349 
described.[48, 49] Utilising established methods, urine samples underwent 1H-NMR, 350 
reversed-phased (RP) and hydrophilic interaction chromatography (HILIC) profiling 351 
experiments. Faecal samples underwent 1H-NMR, hydrophilic interaction chromatography 352 
(HILIC) and bile acid UPLC-MS profiling experiments and GC-MS targeted SCFA 353 
analysis.[49-51] 354 
 355 
After data pre-processing,[52] the resulting 1H-NMR and LC-MS data sets were imported 356 
into SIMCA 14.1 (Umetrics) to conduct multivariate statistical analysis. Principal Component 357 
Analysis (PCA), followed by Orthogonal Partial Least Squares Discriminant Analysis 358 
(OPLS-DA) was performed to examine the data sets and to observe clustering in the results 359 
according to the predefined classes. The OPLS-DA models in the current study were 360 
established based on one PLS component and one orthogonal component. Unit variance 361 
scaling was applied to 1H-NMR data, Pareto scaling was applied to MS data. The fit and 362 
predictability of the models obtained was determined by the R2Y and Q2Y values, 363 
respectively. Significant metabolites were obtained from LC-MS OPLS-DA models through 364 
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division of the regression coefficients by the jack-knife interval standard error to give an 365 
estimate of the t-statistic. Variables with a t-statistic ≥ 1.96 (z-score, corresponding to the 366 
97.5 percentile) were considered significant. Significant metabolites were obtained from 1H-367 
NMR OPLS-DA models after investigating correlations with correlation coefficients values 368 
higher than 0.4. Univariate statistical analysis (Mann-Whitney U test) was used to examine 369 
the SCFA data set. P-values were adjusted for multiple testing using the Benjamini-Hochberg 370 
False Discovery Rate (pFDR) method. 371 
 372 
Confirmation of metabolite identities in the NMR data was obtained using 1D 1H NMR and 373 
2D 1H-1H NMR and 1H-13C NMR experiments. In addition, statistical tools such as SubseT 374 
Optimization by Reference Matching (STORM) and Statistical TOtal Correlation 375 
SpectroscopY (STOCSY) were also applied.[53, 54] Confirmation of metabolites identities in 376 
the LC-MS data was obtained using Tandem MS (MS/MS) on selected target ions. 377 
Metabolite identification was characterized by a level of assignment (LoA) score that 378 
describes how the identification was made.[55] The levels used were as follows: LoA 1: 379 
Identified compound, confirmed by comparison to an authentic chemical reference. LoA 2: 380 
MS/MS precursor and product ions or 1D+2D NMR chemical shifts and multiplicity match to 381 
a reference database or literature to putatively annotate compound. LoA 3: Chemical shift (δ) 382 
and multiplicity matches a reference database to tentatively assign the compound. (For 383 
further details see supplementary methods). 384 
 385 
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FIGURE LEGENDS 579 
Figure 1 | Comparison of phylogenetic constructions from metagenomic and 16S rRNA 580 
gene sequencing sourced from all participants. Phylogenetic trees derived from (A) 581 
metagenomic sequencing and (B) 16S rRNA amplicon sequencing. Taxonomic levels are 582 
assigned from centre out with kingdom level assignment in centre and strain level assignment 583 
in outer most ring. Dark blue radial highlights correspond to poorly identified taxonomies 584 
(i.e. ‘unknown’ and ‘unassigned’ database entries). Number of assignments at each level of 585 
phylogeny is displayed below the respective graph. Taxonomic trees derived from the two 586 
sequencing approaches illustrate an advantage of metagenomic sequencing in the number of 587 
22 
 
predictions of lower taxonomic levels and the frequency of full identification of taxa, while 588 
16S rRNA sequencing grants greater insight of high level phylogenies within the population. 589 
 590 
Figure 2 | Group-wise comparison of microbial metagenomic and metabolomic profiles. 591 
(A) Shannon index of diversity for metabolic pathways from all three groups. Pathway 592 
diversity is increased in the athlete group when compared to low BMI and high BMI controls. 593 
Diversity measures are statistically significant between low BMI and athletes (p < 0.049), 594 
with statistical significance between all groups (Kruskal Wallis p < 0.05). (B) Principle 595 
coordinate analysis (PCoA) of Bray-Curtis compiled distance matrix of all microbial 596 
metabolic pathway relative abundances. Groups show significant variation from one another 597 
(Adonis PERMANOVA p < 0.05). (C & D) Cross validated orthogonal partial least squares 598 
regression discriminant analysis (OPLS-DA) of full Nuclear Magnetic Resonance (1H-NMR) 599 
spectra from urine (R2Y=0.86, Q2Y=0.60)(C) and faecal water (R2Y=0.86, Q2Y=0.52)(D) 600 
samples. OPLS-DA displays robust separation between athletes and controls. Models are 601 
comprised of 1 predictive (tcv[1]) and 1 orthogonal (tocv[1]) principal component. 602 
 603 
Figure 3 | Group variation of microbial metabolic function and associations between 604 
pathways and clinical and dietary variables. (A) Mean relative abundance values of 605 
statistically significant (Kruskal Wallis p < 0.05) metabolic pathways binned according to 606 
categories of metabolic function. (B) Number of metabolic pathways significantly 607 
(Benjamini-Hochberg corrected p < 0.05) correlated with dietary constituents and blood 608 
serum metabolites. 609 
 610 
Figure 4 | Athletes display a profile of Short Chain Fatty Acids that alters from that of 611 
the controls. (A) Heat map of bacterial taxa (family, genus, and species level) that correlate 612 
with faecal short-chain fatty acid levels using Spearman’s correlation. Cool colours represent 613 
positive correlations; hot colours represent negative correlations (r). All taxa shown had a 614 
correlation p-value < 0.01. Those marked * represent correlations with a pFDR < 0.01 after 615 
Benjamini-Hochberg multiple testing corrections. (B) Median concentrations of GC-MS 616 
derived faecal short chain fatty acid. Quantitative analysis of SCFAs in faecal samples shows 617 
significant increase in measured concentrations of acetate, propionate, butyrate, and valerate 618 
in athletes. Error bars represent 95% confidence intervals. * Data statistically significant (p < 619 
0.05 after Benjamini-Hochberg corrections). (C) Quantification of statistically relevant 620 
correlations of metabolic pathways to GC-MS derived faecal SCFA concentrations (μM). 621 
 622 
Figure 5 | Distinctive association profiles of metabolic pathways to metabolites in 623 
athletes and controls. (A) Significant correlations of faecal water derived metabolites and 624 
metabolic pathways, represented by number of correlations for each metabolite. (B) Urine 625 
metabolites significantly correlated to pathways and displayed as number of correlations. (C) 626 
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Significant correlations shown in (A) displayed as proportions of total associations. (D) 627 
Correlations presented in (B) given as proportions of total associations. 628 
